Pfizer CEO Does Not Deny the Possibility of a Vaccine-Resistant COVID-19 Variant
Business

Pfizer CEO Does Not Deny the Possibility of a Vaccine-Resistant COVID-19 Variant

Despite the possibility of a vaccine-resistant COVID variant, Pfizer CEO states that a new vaccine would be available much faster if necessary.
Trump Says White House Staff Won’t Have Priority for the COVID-19 Vaccine
Politics

Trump Says White House Staff Won’t Have Priority for the COVID-19 Vaccine

President Trump announced in the statement that White House senior staff would get the vaccine at a later stage of the roll-out and that essential workers would be placed at the front of the line at this time.
Here’s What To Know About The First Effective Coronavirus Vaccine
Technology

Here’s What To Know About The First Effective Coronavirus Vaccine

News of a vaccine sent the US financial markets soaring this week and there’s real hope that maybe we may have taken a giant step in dealing with the virus once and for all.
COVID-19 Vaccine Developer CureVac Increases 431% in Value After IPO
Business

COVID-19 Vaccine Developer CureVac Increases 431% in Value After IPO

The company has seen its value grow by a whopping 431% since its Initial Public Offering. As a result, CureVac was able to get up to $231 million in initial funding, which is expected to go towards research and development.

Thank you! You have been added
to our daily newsletter.

We just added to our newsletter list.
Keep an eye out for the latest news from cursor in your inbox!

OK, GOT IT